Chinese Gene Editing Startup EdiGene Raises RMB450 Million

This Data Is Locked!

This area is available only to Subscribers.

Biotechnology company EdiGene today announced the completion of a RMB450 million yuan in series B financing. This round of financing was led by 3H Health... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?